Oral Contraception-Tyler MBRcITo 847 Discussion It has been quite definitely established that progestogenoestrogen oral contraception is very effective with certain recognized but not serious side-effects. Our more recent efforts, and those of most other investigators of these compounds, have taken two major directions: (1) a search for better and lowerdosage products; (2) a detailed investigation of the possible long-term effects of these compounds on various organs and body functions, and the determination of the safety, or lack of safety, of many years of consistent use by the same individual.
body functions, and the determination of the safety, or lack of safety, of many years of consistent use by the same individual.
Since most women now using these products generally take them for family-planning purposes rather than to avoid any further pregnancies, data on long-term continuous use are not easy to obtain. In our clinic the number of women who have used any of our oral contraceptive preparations for over five years continuously is less than 300, and our studies, with those of Pincus, constitute the longest investigations of this form of contraception. Therefore the total number of continuous users for over five years anywhere is likely to be very limited. It is important that long-term data about continuous use be obtained, because, as this form of contraception is being employed more and more by younger women, we will have millions who may complete their families between the ages of 25 and 30, and they will be depending on the continuous use of these products for another 15 to 20 years.
The detailed blood-chemistry studies we have referred to in this report provide one method of obtaining needed information regarding safety. One problem in obtaining this type of information is that certain abnormalities may be found, and they are not necessarily suggestive of pathology. This may hold particularly true, for example, for such changes as elevations in protein-bound iodine. One would be rash, I believe, in deducing a state of hyperthyroidism because the proteinbound iodine in a patient exceeded the usual normal limit of 8 ttg./100 ml. We therefore have to attempt to correlate any changes in chemical findings with the overall physiological alterations occurring during use of the oral contraceptives. This task of obtaining the data, finding suitable controls, and making the necessary correlation is not an easy one. We would like to extend our thyroid-function tests to those studies employing radioactive material, but this presents a problem when pregnant " controls" are used.
We are currently also finding stumbling-blocks in discovering suitable tests for adrenocortical function that can be employed readily in pregnant patients, with no medical or medico-legal risk. Fortunately, the reputable pharmaceutical manufacturers involved with these preparations, as well as various research organizations, are anxious to obtain all the information possible, and there is little problem regarding support in this respect. It is likely that, despite the obvious obstacles, the next few years will bring about an elucidation of the manifold effects that progestogen-oestrogen contraception may have. So far, we know they are extremely effective and we have no definite evidence of serious toxicity. We also know that it requires very small amounts of these agents to provide efficacious contraception. In the case of norethisterone the dose is now down to 2 mg. (with 0.1 mg. of mestranol), and the minimal effective dose may even be lower, a matter we are now in the process of investigating. Summary A brief review of eight years' study of oral contraception is given. Reference is made to detailed blood-studies carried out on patients using various preparations, and a discussion of certain of the findings is presented. In general, while some chemical factors were altered, it is very possible that these are not evidence of a pathological change, but, rather, may be attributable to the pseudopregnancy state. These studies are being continued and expanded.
An analysis of over three years' study of the 2-mg. norethisterone product is also presented. The arterial set consists of a length of light flexible P.V.C. tube with sampling side-arms, self-sealing rubber insert for regional heparinization, pump tubing for use with either sigmamotor or roller pump (sigmamotor pump tubing is illustrated), and a bypass tube should the pump not be required.
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The combined air-trap and filter consists of a filter fitted with two side-arms, one for a manometer and the other for a syringe to allow adjustment of fluid level. The upper half of the trap contains a plastic float with a rubber to plastic self-sealing hole. If the blood in the trap falls to a level below 1 in. (2.5 cm.) above the outlet, blood-flow is completely occluded; this prevents air being returned to the patient in case of mishap.
The venous set consists of a simple light flexible P.V.C. tube with a self-sealing rubber insert for infusion of protamine sulphate during regional heparinization.
As noted earlier, the manufacturers recommend that the coil should be allowed to blow-up into a spherical form. The total volume of fluid contained by the Minicoil under these conditions is approximately 2.5 1. ; the weight of this fluid was largely responsible for the tearing of the suspensory system we experienced in our initial trials.
The modified version of the coil has two tubes for the bath circuit; with the outlet tube at a level at least 3 ft. (0.9 m.) below that of the coil the dialysing fluid siphons and the P.V.C. envelope collapses, forming a tighter seal around the periphery of the coil ; the volume of the dialysate dead space is significantly reduced and the coil may be left free-standing.
Reduction in the volume and pressure of the dialysing fluid in the P.V.C. envelope reduces the resistance to the flow of blood through the cellophane tubing. It is believed that the improved efficiency of dialysis to be reported is largely due to the alteration of the dialysing-fluid circuit and the resultant improvement in flow of blood.
The modified coil, arterial set, venous set, and air-trap are colour-coded and connect to the coil with male and fenale Luer fittings arranged in such a way that the complete dialysing unit can be assembled only in the correct manner.
Results
Clearance from Aqueous Solutions.-To assess the efficiency of the modifications, two solutions of urea in saline containing 250 mg. urea/100 ml. and 500 mg. urea/100 ml. respectively were dialysed against normal saline (0.9 g. NaCl/l.). After 30 minutes' equilibration for any given set of bath and bloodflow rates, clearances were determined in triplicate at 15-minute intervals.
Urea Clearance.-Calculation from the data of Lawson et al. gives a blood-urea clearance of 24 ml./min. from artificial solutions at a blood-flow rate of 100 ml./min. Fig. 2 Fig. 3 indicates the rate of removal of water in ml./hr. for varying glucose concentrations at a blood-flow rate of 100 ml./min. Fig. 4 Dialysis was begun when the plasma urea was over 250 mg./ 100 ml. Blood was pumped at 100 ml./min. until the plasma urea had fallen to 150 mg./100 ml. or below, blood sampling being undertaken at 12-hourly intervals, after which the pump was bypassed. Pumping was started again if the blood-flow rate of 50 to 80 ml./min. was not sufficient to maintain the plasma urea in the range 150-200 mg./100 ml. In practice Cases 1, 5, and 6 were dialysed without the pump at night but had periods of pumping during the day. It is considered that when using this apparatus a pump will be required for most patients from time to time. Continuous Dialysis-Blackmore and Mitchell WDICBL JOUNAI this time the patient's plasma urea fell from 165 to 135 mg./100 ml., with a blood-flow rate of 100 ml./min. Dialysis was restarted the next day, lasted 83 hours, then stopped for 41 hours, and a final 20-hour dialysis was undertaken at the onset of the diuretic phase.
Daily blood urea, plasma potassium, and urine outputs are charted in Fig. 5 .
Daily weight changes were noted. The average loss of weight in patients with acute renal failure is 0.2 to 0.3 kg./day. This rate of loss occurred in the patient, with a fluid intake of 1,500-2,000 ml./day in excess of output compared with the 400-500 ml./day usually allowed in patients not being dialysed. This suggests that 1,000-1,500 ml. of water were lost daily by ultrafiltration. As the patient was not clinically overhydrated no attempt was made to increase the rate of water loss by increasing the resistance to venous outflow. Nor was this done in any of the other patients, so in vivo measurements are required to confirm in vitro experiments on water removal. Discussion Dialyses are carried out for varying lengths of time, depending on the clearance of the apparatus and factors such as the initial level of the blood urea. When dialysis is used intermittently, periods commonly employed are four and a half hours for rotating drum and six hours for Kolff twin-coil "artificial kidneys." The modified Minicoil would be correspondingly employed for 24 to 30 hours. However, in the present cases dialysis was at times continued for much longer periods in an attempt not only to lower the blood urea and correct plasma electrolyte abnormalities but to maintain the biochemical improvement.
Over 400 dialyses have been carried out in this unit using a Kolff twin-coil artificial kidney. Advantages of the Minicoil compared with this well-tried apparatus appear to be: (a) blood is not required for priming-normal (0.9%.) saline was used, the volume ranging from 250 to 300 ml. ; (b) maintenance of the lowered blood urea and corrected plasma electrolytes allows surgical procedures to be undertaken at any time during the period of acute renal failure with less risk than in patients being infrequently intermittently haemodialysed; and (c) the slower clearance of urea reduces the tendency to development of the dialysis disequilibrium syndrome-a feature of uraemia and rapid clearance of urea by dialysis (Kennedy et al., 1962 (Kennedy et al., , 1963 Cowie et al., 1962) .
However, the use of the modified Minicoil for continuous dialysis has produced several problems:
Staffing.-Lack of inbuilt safety devices has necessitated continuous supervision by highly trained medical, technical, and nursing staff. Under these circumstances this method of treatment could not be used routinely in the treatment of acute renal failure. 
